Some studies have further shown that BDNF/TrkB can increase neuroblastoma metastasis via the PI3K/Akt/mTOR and MAPK pathways, indicating that BDNF/TrkB and its downstream targets may be potential therapeutic targets for treating neuroblastoma metastasis [42]. The gene discussed is AKT1; the disease is neuroblastoma.